Atherosclerosis Supplements

15.1k citations
1.7k papers · · active since 1950

Impact in

Papers in

Atherosclerosis Supplements

1.3k papers receiving 13.5k citations

Peers

Atherosclerosis Supplements
Comparison fields: 5 of 176
  • Endocrinology, Diabetes and Metabolism 2.6k
  • Surgery 5.4k
  • Cardiology and Cardiovascular Medicine 2.6k
  • Nutrition and Dietetics 1.3k
  • Cancer Research 1.2k
Replace American Journal of Therapeutics with:
American Journal of Therapeutics United States
Journal of Investigative Medicine United States
Clinics in Liver Disease United States
Current Vascular Pharmacology Greece
Archives of Medical Science Poland
Nephrology Australia
Expert Opinion on Drug Safety United States
Journal of Cardiovascular Pharmacology and Therapeutics United States
Journal of Nephrology Italy
Annals of Hepatology Mexico
Atherosclerosis Supplements relative to American Journal of Therapeutics United States American Journal of Therapeutics's profile →
Citations per field
00.5×1.5×2.0×
American Journal of Therapeutics · 1×
Citations per year

Countries where authors publish in Atherosclerosis Supplements

Since Specialization
Citations

This map shows the geographic impact of research published in Atherosclerosis Supplements. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Atherosclerosis Supplements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atherosclerosis Supplements more than expected).

Fields of papers published in Atherosclerosis Supplements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Atherosclerosis Supplements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Atherosclerosis Supplements.

About Atherosclerosis Supplements

The 1.7k papers published in Atherosclerosis Supplements in the last decades have received a total of 15.1k indexed citations . Papers published in Atherosclerosis Supplements usually cover Endocrinology, Diabetes and Metabolism (256 papers), Surgery (551 papers), Cardiology and Cardiovascular Medicine (279 papers), Cancer Research (184 papers) and Biochemistry (47 papers) specifically the topics of Lipoproteins and Cardiovascular Health (409 papers), Cancer, Lipids, and Metabolism (150 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (132 papers), Atherosclerosis and Cardiovascular Diseases (84 papers), Lipid metabolism and disorders (70 papers), Cholesterol and Lipid Metabolism (69 papers), Cardiovascular Disease and Adiposity (67 papers) and Adipokines, Inflammation, and Metabolic Diseases (60 papers). The most active scholars publishing in Atherosclerosis Supplements are Terje R. Pedersen, Philip J. Barter, John P. Cooke, Marja‐Riitta Taskinen, Yūji Matsuzawa, Thomas Münzel, Karsten Sydow, Naveed Sattar, M. John Chapman and Ulrich Julius.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact